Preparing To Use Resonant Acoustic Spectroscopy with Optical Vibrometry to Characterize the Clot Elastic Modulus from Mice with Sickle Cell Disease by Segerstrom, Kara J.
  
 
 
 
 
Preparing To Use Resonant Acoustic Spectroscopy with Optical Vibrometry to 
Characterize the Clot Elastic Modulus from Mice with Sickle Cell Disease 
By 
Kara J. Segerstrom 
 
Seniors Honors Thesis 
Department of Biomedical Engineering 
University of North Carolina at Chapel Hill 
 
March 31, 2017 
 
 
 
Approved __________________ 
Amy L. Oldenburg, Thesis Advisor 
Alisa S. Wolberg, Reader 
Devin Hubbard, Reader  
PAGE	 2	
	
Table of Contents 
Abstract                     3 
Introduction                     3 
Theory                               4 
Overall Principal                    4 
Hardware                     5 
Signal Processing                    5 
Methods                     6 
Texture Analyzer                 6 
Microwell Calibration                    7 
Blood Clot Preparation                7 
Results                  8 
Texture Analyzer                 8 
Reduction of Microwell Sizes               9 
Calibration of CEMport to the Flat Bottom Wells                      11 
Preliminary Blood Data                                         12 
Conclusion                13 
Acknowledgements               14 
References                14 
	
 
 
 
 
 
 
PAGE	 3	
	
1. Abstract: 
CEMport is machine that uses resonant acoustic spectroscopy with optical vibrometry to find 
the clot elastic modulus. In order to prepare CEMport for future experiments on sickle cell 
disease, CEMport will be calibrated. The device was previously calibrated to a 150µL cube 
microwell, but the following study will calibrate CEMport to a 100 µL cylindrical microwell. 
Microwells with sample sizes 150µL, 125µL and 100µL were tested, and the results 
demonstrated that all three sizes were able to produce quality fits. The sickle cell blood clots will 
be formed from mice, therefore the reduction of sample size will allow more samples to be 
created. The calibration coefficient a0 in the equation: 𝐸 = 𝑎!𝜌𝑓!!, was found to be 0.063 ± 0.002 
Pa/Hz2, whereas the previously found ratio was 0.076 ± 0.003 Pa/Hz2. Preliminary testing of 
blood clots for human and mouse whole blood was 1.94 ± 0.03kPa and 2.98 ± .33kPa 
respectively, falling within the expected range of elasticity.  
 
2. Introduction: 
 Altered mechanical structures of blood clots have been related to cardiovascular disease 
such as coronary heart disease [1], heart attack [2], and diabetes [3]. The clot elastic modulus, 
CEM, is a parameter for defining clot physical characteristics [4]. CEM refers to the stiffness of 
a clot and reflects the combined structure of blood clot components such as platelets, fibrin, and 
erythrocytes [4]. Blood clots are required to be stiff to prevent the flow of blood when vessels are 
wounded [5], yet still elastic enough to be broken apart by mechanical forces [6]. When blood 
clot mechanical properties are abnormal, it can lead to an increased risk of bleeding or 
thrombosis [5].  The elastic modulus of individual fibers of a blood clot may be measured using 
optical tweezers, but a method for testing whole blood clots is lacking. TEG is the current device 
used to test elasticity; however, its main purpose is recording the blood clotting time. The TEG 
5000 has a sample size of 360µL, which is not ideal for testing animals with low blood volumes. 
CEMport is a machine that can precisely record the CEM using resonant acoustic spectroscopy 
with optical vibrometry (RASOV). A main advantage of CEMport is the low sample size of 
150µL, which is further reduced as described in this paper. 
 In order to lower the sample size of CEMport, the first step is to use a texture analyzer to 
calibrate CEMport to the elastic modulus and represent the standard for Young’s modulus. The 
next step is to test different microwell sizes and shapes. The following sizes are tested: 150µL, 
125µL and 100µL. Two different shapes are tested in aforementioned sizes. The original shape 
of the microwell was a cube, but it was found that there was sample residue in the corners and 
can be difficult to clean. The new shapes have fewer creases in order to prevent residue and 
described in more detail in the methods sections. The calibration is completed after using 
CEMport on the new microwells. Further calibration explanation can be found in the theory 
section. Finally, blood clots from humans and mice are tested on to ensure the validity of the 
calibration. The ultimate goal of CEMport is to be able to test blood clots from mice with sickle 
cell disease, which explains the importance of a low sample size. Mice samples from our partner 
produce around 500 to 600µL. Ideally if the sample size was reduced from 150µL to 100µL, 2 to 
3 more samples could be produced per mouse for a total of 5 to 6 samples. The TEG 5000 in this 
case would only be able to produce 1 to 2 samples.  
 Roughly 90,000 to 100,000 Americans currently live with sickle cell [8]. A survey 
completed in 2010 found that 15.5 out of 1,000 American newborns presented sickle cell trait, 
and American black newborns had a rate of incidence as high as 73.1 out of 1,000 [9]. Patients 
with sickle cell disease will often have pain as a result of blockages due to clotting, and a third of 
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patients will develop chronic kidney disease and end-stage renal disease [8]. CEM has already 
been related to several other cardiovascular diseases and thus is an important tool for researchers, 
aiding them in understanding the effects of clot stiffness on cardiovascular health. Sickle cell 
disease has an altered mechanical state due to increased levels of fibrin, and thus can also be 
characterized and potentially identified by CEM [5]. By improving CEMport’s ability to 
distinguish pathologies among clots, CEMport will benefit the medical and research community 
as a novel and precise method of the elastic assessment of blood. Sample size reduction will 
provide CEMport an obviously advantage with small animal research testing. 
Previous research using CEMport include studies on how fibrinogen and heparin affect 
the CEM. CEMport has proven its ability to distinguish clots with varying levels of fibrin and 
provide insight into clot stiffness [7]. CEMport can detect changes in elasticity of clots between 
0.5 and 6 mg/mL of added fibrinogen content [7]. In another study, it was found that CEMport is 
sensitive to heparin levels below 0.050 U/mL; meaning CEMport could potentially be used in 
surgical management [4].  
 
3. Theory 
a. Overall Principle 
CEMport uses resonant acoustic spectroscopy with optical vibrometry, RASOV, as the 
principle method to find the CEM. Resonance refers to the main measurement taken by 
CEMport. A magnetic field causes a microbead to vibrate on top of a clot sample, and the 
displacement caused by the resonance is recorded. More details of the data collection are 
described below in the hardware section. Using resonance as a measurement is ideal, because the 
measurement allows for high signal to noise ratio and easy signal reproducibility [4]. The 
resonance frequency is related to CEM using the following equation: 𝐸 = 𝑎!𝜌𝑓!!, where E is the 
elastic modulus, 𝜌 is sample mass density, 𝑓! is the fundamental resonance frequency and 𝑎! is 
an experimentally determined calibration coefficient [10]. The experimentally determined 
calibration coefficient is derived from the ratio of a1 and a2 from the following two equations: 𝐸 = 𝑎!(𝑐 − 𝑐!)! and 𝑓! = 𝑎!(𝑐 − 𝑐!) where c is agarose concentration. Agarose is being used to 
calibrate CEMport, thus why 𝜌 is required to adjust the equation for blood clots. The variables a1 
found in the first equation are calculated from a plot of agarose concentration along the x-axis 
and elasticity along the y-axis. The elasticity of the agarose is found using a texture analyzer that 
compresses the sample. The stress and strain at varying values of strain from the compression 
test is then used to find the elasticity. The second equation has agarose concentration along the x-
axis and resonance frequency along the y-axis in order to calculate the variable a2 and c0. The 
value found for c0 is used in the fitting for the texture analyzer. The resonance frequency is found 
using CEMport. The concentrations of agarose in both fittings are roughly within the same range. 
The next part of RASOV is the acoustic spectroscopy, which refers to the frequencies produced 
by the vibration of the blood clot Acoustic spectroscopy is the method the resonance is captured 
by CEMport. The displacement data of the blood clot during vibration is converted into the 
frequency domain and thus can be fitted to find the resonance. A detailed description of signal 
processing can be found in the signal processing section. Lastly, optical vibrometry refers to the 
laser tracking the displacement of the microbead, which is described in the hardware section 
below.  
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b. Hardware 
From the laptop that controls CEMport, the user-selected parameters are outputted to a 
waveform generator. The parameters include the highest frequency the chirped waveform 
reaches, the voltage of the chirped 
waveform, and sampling rate of both 
the waveform generator and data 
acquisition card (DAQ). The 
waveform generator creates a chirped 
waveform based off of the parameters 
and sends the signal to a power 
supply that amplifies it. The power 
supply is connected to a solenoid that 
produces a magnetic field. An arm 
holds a microwell above the solenoid, 
which contains the clot sample. A 
microbead is placed on top of the 
sample in the middle with a 
displacement laser focused on it. The 
displacement laser is moved using an 
XYZ stage powered by motors that 
allow the user to center the laser on the microbead. The magnetic field pulls on the microbead 
causing a displacement in the Z-axis that can be tracked by the laser. The displacement sensor 
sends the information to the displacement sensor controller, which is able to convert the 
displacement data into voltage increments that is sampled by the DAQ. A humidifier that keeps 
samples moist during testing surrounds the XYZ stage, the sample arm, the laser, and the 
solenoid.  
 
c. Signal Processing 
	The	overall	goal	of	the	signal	procecessing	is	to	find	the	
elastic	modulus.	The first step of the signal processing is to 
convert the displacement information from the vibrating 
microbead into frequency data. The frequency data can be 
fitted in order to provide the resonance, which is then 
related to the CEM. The displacement data of the microwell 
is taken twice, once when the magnetic field is turned on 
and another when the field is off. Then the data is converted 
into the frequency domain using a Fourier transform. The 
chirped waveform is also converted into the frequency 
domain and divided from both the B-on and B-off data 
defined above in order to isolate the impulse response. The 
B-off data is subsequently subtracted from the B-on data to 
remove any potential noise. The absolute value of output from the pervious step is now the 
amplitude data and can be view in figure 2. The phase data is computed from the amplitude data 
enabling the information to be as shown in figure 3. 
Figure 2: Amplitude Fitting from 
CEMport  
Figure 1: Flow Chart of CEMport’s Hardware [4] 
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 Now the amplitude and phase data needs to be fitted 
in order to find the resonance information. As demonstrated 
in figures 2 and 3, there is an obvious peak and phase change 
in the respective images.  The user begins the fitting process 
by inputting the maximum frequency of the data as well as a 
resonant frequency guess. First the code fits the amplitude 
data using the equation: 𝐴 𝑤 = !(!!!!!!)!!!!!!!, where ω0,  
γ and q are fitted to the data using least squares fitting. The 
variable ω0 represents the resonant frequency, γ is the spread 
of the resonance and q is a combination of ω0, γ and the 
amplitude of the peak. Next the code finds the slope of the phase change to enable a better fit 
when the phase change fitting is done. The equation for the phase fitting is performed next: 𝜙 𝜔 = tan−1 !!!!!!!!! + 𝛽𝜔. The βω corrects for a time lag in the system due to LabView being 
unable to begin the magnetic field and data acquisition at exactly the same time. Finally, the code 
allows the data and the fit to be seen simultaneously on a graph to ensure the fit is correct.  
 
4. Methods 
a. Texture Analyzer 
The texture analyzer is used as the standard for 
elasticity and used in the calibration coefficient to relate the 
resonant frequency to the CEM. The agarose samples were 
prepared by first measuring out 50.0 mL of distilled water into 
a closable tube for each individual sample using a graduated 
cylinder. The weight of the agarose is recorded before being 
added to the distilled water, and again afterwards, to best 
determine the precise amount of powder added, and therefore 
the actual concentration of agarose solution. The tubes, now 
filled with distilled water and agarose power, are closed and 
placed in a hot water bath set to 90 ± 5 °C for 20 minutes. The 
sample solutions are periodically shaken gently to ensure even 
suspension of the now melted agarose. After sitting in the hot 
bath, the agarose is cooled in the refrigerator for five minutes 
and poured into a cylindrical mold, sized to fit on the texture 
analyzer, resting in a culture dish. The purpose of placing the 
agarose in the refrigerator is to lower the temperature to the 
point right before it becomes a solid so that when it is poured 
into the mold, the smallest amount of agarose leaks out from 
under the mold due to the sample becoming a solid rapidly. 
The cover of the dish is placed over the mold to seal in 
moisture. A weight is set on top of sample for 10 minutes, to 
ensure that the mold is flush with the dish and that agarose solution will not leak outside of the 
mold. The agarose sample is placed in the refrigerator overnight to set.  
          A texture analyzer (TA.XT Plus) compresses the agarose sample in order to find the 
parameters that allow stress and strain to be calculated. The agarose samples are removed and 
left out for 30 minutes or until they reach room temperature. The samples are carefully placed on 
Figure 3: Phase Fitting from 
CEMport  
Figure 4: Texture analyzer 
with agarose sample 
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the testing platform of the texture analyzer. The texture analyzer compresses the samples and the 
following data is collected: distance of compression, time, the height of the sample and force. 
The samples were pre-compressed until consistent data was collected, as opposed to collecting 
the data as the sample were first experiencing the compression. Consistent data refers to the 
samples being compressed until the slope of the curve has stabilized. Engineering strain and 
stress information is calculated by hand in an excel spreadsheet. Stress is the force over the area. 
The force is gathered from the texture analyzer, and the area was calculated using a caliber on 
the mold. Stress is the change in distance over the height of the mold. Both parameters are found 
using the texture analyzer. The slope of strain and stress is used to find the elasticity of each 
sample.   
 
b. Microwell Calibration 
Microwell calibration experiments test three different sample sizes and two different 
shapes to determine which of the microwells can be used for calibration. Water is filtered before 
being pipetted into closable tubes. A 1000µL pipette transfers the filtered water in 1mL intervals 
to prepare 10 mL in the tubes. Agarose powder is weighed in a dish and then poured into its 
corresponding tube. The weigh dish is measured again afterwards to ensure an accurate 
measurement.  The tubes are gently shaken and placed into a water bath of 90 ± 5 °C for 20 
minutes. The tubes are rotated gently to mix before the agarose solution is pipetted into the 
microwells. The microwells sample sizes include 150µL, 125µL and 100µL. The two shapes 
include cylinder flat bottom and cylinder spherical bottom (refer to figure 5 and 6). The round 
shapes were selected due to concern that original cube shape had sample residue build up in the 
corners. The microwells were placed in the refrigerator overnight. The following day the 
microwells were left out for 30 minutes to reach room temperature within the humidified 
chamber. The microwells were then placed into CEMport with a 0.7mg and 500µm diameter 
steel microbead (grade 25, Salem ball company) placed on top in the middle of the sample. If a 
larger bead is used, the resonance will be dampened and inaccurate data will be produced. The 
user followed the parameters setting described in the Hardware section to locate the resonance 
frequency for each sample. 
 
  
Figure 5: Cylinder Flat Bottom Microwell Figure 6: Cylinder Spherical Bottom Microwell 
c. Blood Clot Preparation 
Blood clots were tested in order to validate the calibration coefficient and perfect methods for 
future testing. Alisa Wolberg at the University of North Carolina at Chapel Hill provided the 
procedure for blood clot preparation as well as supplies. The animal blood protocols were 
approved by the IACUC, and human blood was obtained by protocols approved by the IRB. 
Innovin was diluted with HBS to create a 1:12,000 solution and the calcium was diluted with 
distilled water to 10mM. 5µL HBS, 5µL Ca2+, 5µL Innovin and 85µL blood was pipetted into 
the microwell. The HBS, Ca2+, and Innovin were added in such as way that they do not mix until 
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the blood is added. The blood is pipetted slowly up and down in the microwell to gently mix the 
solution. The wells are placed within the humidified chamber for 45 minutes to ensure the blood 
clots, and then they are tested to find their resonance.  
 
5. Results 
a. Texture Analyzer 
 The texture analyzer is used as a standard for elasticity in order to relate CEM the 
resonance frequency found by CEMport to the CEM. A texture analyzer is used to measure the 
elasticity of agarose by quasi-static compression. By measuring the stress and strain created by 
the compression of the texture analyzer, the elasticity of the agarose was derived. By visual 
inspection of graphs 1 and 2, it is demonstrated that the elasticity of the most recently found data 
is roughly the same as the original data. Table 1 displays the result of the least squares fitting to 
the equation 𝐸 = 𝑎!(𝑐 − 𝑐!)!, which is discussed in the background. The original a1 was 706 ± 
10, while the new experimentally found a1 was 562 ± 13 [4]. The a1 value is slightly lower than 
expected due to falling outside of experimental error; however, it is suspected that the different 
results are due to a change in method. In the recent experiments, the samples were pre-
compressed until consistent data was collected, as opposed to analyzing the data as the sample 
were first experiencing the compression. Consistent data refers to the samples being compressed 
until there is no change in elasticity measurements.  Due to this change in methods, the resulting 
elasticity measurements might be expected to change as well.   
 
Graph 1: Current Data of the Elasticity of Agarose Using a Texture Analyzer 
 
Graph 2: Original Data of the Elasticity of Agarose Using a Texture Analyzer [4] 
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Table 1: Result of the Least Squares Fitting of the Elasticity Data from the Texture Analyzer  
Variable Current Original [4] 
a1 562 +/- 13 702 +/- 10 
R2 0.9954 0.9982 
 
b. Reduction of Microwell Well Size 
The original microwell is 150 µL and cuboid shaped, but a goal for this experiment is to 
reduce the sample size. The two designs are the cylinder flat bottom and cylinder spherical 
bottom microwells in the sizes 150 µL, 125 µL and 100 µL. The shape change is a preventative 
measure against the samples leaving residue in the corners of the well. The rounded edges will 
make the well easier to clean and increase the likelihood of a more accurate sample volume.  
After experimenting with both shapes and sizes, it was demonstrated that the 100µL flat 
and spherical bottom microwells provided results with good fits. The flat bottom microwells 
were chosen due to the blood clot preparation requires keeping the different solutions separate 
until blood is added, which would be impossible with the spherical bottom. The flat bottom 
microwells also had higher resonances, which may be beneficial due to the fact blood has low 
stiffness and therefore resonates at lower frequencies. The lower the frequencies are less accurate 
due to the range of frequencies agarose is able to reach, therefore higher frequencies are ideal. 
 
Graph 3: Acoustic Spectrograph of 100µL Flat Bottom Microwell at 3 mg/mL Agarose 
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Graph 4: Acoustic Spectrograph of 100µL Flat Bottom Microwell at 3 mg/mL Agarose 
Concentratio 
 
 
Graph 5: Acoustic Spectrograph of 100µL Spherical Bottom Microwell at 3 mg/mL Agarose 
Concentration 
 
Graph 6: Acoustic Spectrograph of 100µL Spherical Bottom Microwell at 3 mg/mL Agarose 
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c. Calibration of the CEMport to the Flat Bottom Wells 
To complete the calibration of CEMport, the resonance of the agarose needs to be fitted to 𝑓! = 𝑎!(𝑐 − 𝑐!), which is described in more detail in background. Graphs 7 and 8 contain the 
flat bottom microwell data and the original cuboid data respectively. The a2 variable found was 
98.9 ±  5.3, while the original was 99.8± 1.0. The found c0 value was 0.67± 0.2 and the original 
was 0.97± 0.05 [4].  Further details can be referenced from table 2. The a2 variable was found to 
be within experimental error of the cube shape microwell, which is surprising due to the change 
in geometry; however, the c0 variable was found to be lower than the original cube shape. The 
similarity in the a2 may be the result of having a similar boundary condition. The height of the 
cuboid microwell was 5 cm, while the height of the cylindrical microwell was about 5.03 cm.  
The drastic change in the c0 variable may possibly be the result of the agarose absorbing 
moisture over time. The same agarose used in the original CEMport calibration was used in this 
study, therefore the agarose is approximately 3 years old.  With both a1 and a2 now calculated, a0 
in the equation 𝐸 = 𝑎!𝜌𝑓!! may be found. The variable a0 was found to be 0.063 ± 0.002 Pa/Hz2, 
whereas the original ratio was 0.076 ± 0.003 Pa/Hz2. The adjusted ratio may be due to the change 
in method for the texture analyzer rather than the change in geometry.  
 
Graph 7: 100µL Flat Bottom Resonance Frequency of Agarose Using CEMport 
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Graph 8: Original Data of the Resonance Frequency of Agarose Using CEMport [4] 
Table 2: Summary of Coefficients of Fit for Flat Bottom Agarose Wells 
Variable Current Original [4] 
a2 (Hz•mL/mg) 98.9 +/- 5.3 99.8 +/- 1.0 
c0 (mg/mL) 0.67 +/- 0.2 0.97  +/- 0.05 
R2 0.9916 0.9984 
 
d. Preliminary Blood Data 
Preliminary blood data is shown in graphs 9 and 10 for human and mouse whole blood 
respectively. The elasticity for the human whole blood was 1.94 ± 0.03kPa and mouse was 2.98 
± .33kPa. Both fall with the average range blood clot elasticity of 1.7 and 5 kPa [7]. In the future, 
the elasticity may be compared with TEG. The mouse blood will also be practiced with until 
error is reduced. After perfecting the blood clot method, mice with sickle cell disease will be 
tested. 
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Graph 9: Elasticity of Human Whole Blood Found by CEMport 
 
Graph 10: Elasticity of Mouse Whole Blood Found by CEMport 
 
6. Conclusion 
The main motivation behind the presented research is to prepare CEMport for finding the 
elasticity of blood clots taken from mice with sickle cell disease. CEMport demonstrated its 
ability to reduce its original sample size from 150 µL to 100 µL while maintaining fit quality. 
The reduction in microwell size impact was clear when whole mouse blood was tested. Instead 
of having three samples with the 150µL microwells, our lab was able to create five 100µL 
samples. Undoubtedly, this is an advantage when working with small animals such as a mouse. 
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There are some disadvantages to the smaller well size however, such as a higher rate of peaks 
caused by the microbead not being exactly in the middle of the well. The smaller wells are more 
sensitive to movement in the XY direction, which cause miniature peaks to appear in the 
amplitude fitting. Generally fixing the placement of the microbead or having the fit program 
ignore the miniature peak can rectify this disadvantage. 
The calibration coefficient found in this study was lower than expected; however, there was a 
significant change in methods with the texture analyzer. The pre-compression was not used in 
previous studies, which may have been the main contributor to the change in calibration 
coefficient. Surprisingly, the geometry of the well did not have a large effect on the calibration 
coefficient due to it being within the standard error of the original cube microwell. A potential 
explanation for their similarity is the main factor that causes the resonance is the height of the 
well due to boundary conditions [11]. The height of the well for the flat bottom and cube 
microwell was 5.03cm and 5.00 cm respectively and produced in the same way by the same 
manufacturer.  
Preliminary testing of blood clots from both the human and mouse is promising for future 
study as the results fell within the expected ranges of elasticity for blood clots. The human blood 
compared to the mouse blood had less variability, therefore more practice is required in the 
future for preparing mouse blood. Important limits of the machine include the manual input 
required for recording a sample’s resonance, therefore preventing automatic recording of 
elasticity of time as well as currently not being able to record clotting time. It is also important to 
note that lowest texture analyzer data point for agarose is 2.45± .01kPa; therefore lower elasticity 
values of blood are less certain. Overall, it appears that CEMport will be ready for sickle cell 
blood clot testing in the near future.  
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